| pubmed-article:14993501 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0035648 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0206074 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0020503 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0814435 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:14993501 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:14993501 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:14993501 | pubmed:dateCreated | 2004-4-22 | lld:pubmed |
| pubmed-article:14993501 | pubmed:abstractText | Secondary hyperparathyroidism can complicate renal replacement therapy (RRT) in patients with end-stage renal disease. Current medical therapies often result in hypercalcaemia and fail to correct hyperparathyroidism, but might be more effective at an early stage of disease. The aim of this study was to identify prognostic factors at the start and during the first year of RRT for refractory secondary hyperparathyroidism needing parathyroidectomy (PTx) during long-term follow-up. | lld:pubmed |
| pubmed-article:14993501 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14993501 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14993501 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14993501 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14993501 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14993501 | pubmed:month | May | lld:pubmed |
| pubmed-article:14993501 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:TobéTom J MTJ | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:de JongPaul... | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:StegemanCoen... | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:HuismanRoel... | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:PlukkerJohn... | lld:pubmed |
| pubmed-article:14993501 | pubmed:author | pubmed-author:JornaFrancisc... | lld:pubmed |
| pubmed-article:14993501 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14993501 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:14993501 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14993501 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14993501 | pubmed:pagination | 1168-73 | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:meshHeading | pubmed-meshheading:14993501... | lld:pubmed |
| pubmed-article:14993501 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14993501 | pubmed:articleTitle | Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. | lld:pubmed |
| pubmed-article:14993501 | pubmed:affiliation | Department of Surgical Oncology, University Hospital Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands. f.h.jorna@chir.azg.nl | lld:pubmed |
| pubmed-article:14993501 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14993501 | lld:pubmed |
